Long Noncoding RNA ZEB1-AS1 Downregulates miR-23a, Promotes Tumor Progression, and Predicts the Survival of Oral Squamous Cell Carcinoma Patients

References

• Habbous S, Harland LT, La Delfa A, et al. Comorbidity and prognosis in head and neck cancers: differences by subsite, stage, and human papillomavirus status. Head Neck. 2014;36(6):802–810. doi:10.1002/hed.23360
   PubMed Web of Science ®Google Scholar
• Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11(1):9–22. doi:10.1038/nrc2982
   PubMed Web of Science ®Google Scholar
• Adoch W, Garimoi CO, Scott SE, et al. Knowledge of cervical cancer risk factors and symptoms among women in a refugee settlement: a cross-sectional study in northern Uganda. Confl Health. 2020;14(1):85. doi:10.1186/s13031-020-00328-3
   PubMed Web of Science ®Google Scholar
• Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med. 2010;39(4):299–305. doi:10.1111/j.1600-0714.2009.00845.x
   PubMed Web of Science ®Google Scholar
• Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma–an update. CA Cancer J Clin. 2015;65(5):401–421. doi:10.3322/caac.21293
   PubMed Web of Science ®Google Scholar
• Takahashi H, Yanamoto S, Yamada S, et al. Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases. Int J Oral Maxillofac Surg. 2014;43(6):680–685. doi:10.1016/j.ijom.2013.11.013
   PubMed Web of Science ®Google Scholar
• Khanduja JS, Calvo IA, Joh RI, Hill IT, Motamedi M. Nuclear noncoding RNAs and genome stability. Mol Cell. 2016;63(1):7–20. doi:10.1016/j.molcel.2016.06.011
   PubMed Web of Science ®Google Scholar
• Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354–361. doi:10.1016/j.tcb.2011.04.001
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463. doi:10.1016/j.ccell.2016.03.010
   PubMed Web of Science ®Google Scholar
• Li GY, Wang W, Sun JY, et al. Long non-coding RNAs AC026904.1 and UCA1: a “one-two punch” for TGF-beta-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer. Theranostics. 2018;8(10):2846–2861. doi:10.7150/thno.23463
   PubMed Web of Science ®Google Scholar
• Ni W, Zhang Y, Zhan Z, et al. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. J Hematol Oncol. 2017;10(1):91. doi:10.1186/s13045-017-0449-4
   PubMed Web of Science ®Google Scholar
• Gao S, Zhao ZY, Wu R, Zhang Y, Zhang ZY. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis. Onco Targets Ther. 2018;11:4877–4891. doi:10.2147/OTT.S169823
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang N, Zhang X, Liu H, Yang S. LncRNA ZEB1-AS1 down-regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma. J Cell Mol Med. 2019;23(12):8206–8218. doi:10.1111/jcmm.14692
   PubMed Web of Science ®Google Scholar
• Ma ZJ, Wang Y, Li HF, et al. LncZEB1-AS1 regulates hepatocellular carcinoma bone metastasis via regulation of the miR-302b-EGFR-PI3K-AKT axis. J Cancer. 2020;11(17):5118–5128. doi:10.7150/jca.45995
   PubMed Web of Science ®Google Scholar
• Cheng R, Li N, Yang S, Liu L, Han S. Long non-coding RNA ZEB1-AS1 promotes cell invasion and epithelial to mesenchymal transition through inducing ZEB1 expression in cervical cancer. Onco Targets Ther. 2018;11:7245–7253. doi:10.2147/OTT.S179937
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim SJ, Choo J. miR-23a-3p is a key regulator of IL-17C-induced tumor angiogenesis in colorectal cancer. Cells. 2020;9(6):1363. doi:10.3390/cells9061363
   PubMed Web of Science ®Google Scholar
• Yin L, Xu G, Zhu Y, Wang Y. Expression of miR-23a and miR-135 and tumor markers in gastric cancer patients and the significance in diagnosis. Oncol Lett. 2019;18(6):5853–5858. doi:10.3892/ol.2019.10943
   PubMed Web of Science ®Google Scholar
• Liu P, Wang C, Ma C, Wu Q, Zhang W, Lao G. MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3. Cancer Cell Int. 2016;16(1):67. doi:10.1186/s12935-016-0342-1
   PubMedGoogle Scholar
• Koller K, Das S, Leuschner I, Korbelius M, Hoefler G, Guertl B. Identification of the transcription factor HOXB4 as a novel target of miR-23a. Genes Chromosomes Cancer. 2013;52(8):709–715. doi:10.1002/gcc.22066
   PubMed Web of Science ®Google Scholar
• He Y, Meng C, Shao Z, Wang H, Yang S. MiR-23a functions as a tumor suppressor in osteosarcoma. Cell Physiol Biochem. 2014;34(5):1485–1496. doi:10.1159/000366353
   PubMedGoogle Scholar
• Siegel C, Li J, Liu F, Benashski SE, McCullough LD. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci USA. 2011;108(28):11662–11667. doi:10.1073/pnas.1102635108
   PubMed Web of Science ®Google Scholar
• Noh JH, Kim KM, McClusky WG, Abdelmohsen K, Gorospe M. Cytoplasmic functions of long noncoding RNAs. Wiley Interdiscip Rev RNA. 2018;9(3):e1471. doi:10.1002/wrna.1471
   PubMed Web of Science ®Google Scholar
• Marchese FP, Raimondi I, Huarte M. The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 2017;18(1):206. doi:10.1186/s13059-017-1348-2
   PubMed Web of Science ®Google Scholar
• Sun J, Pan LM, Chen LB, Wang Y. LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis. Cell Cycle. 2017;16(21):2100–2107. doi:10.1080/15384101.2017.1361071
   PubMed Web of Science ®Google Scholar
• Gu P, Chen X, Xie R, et al. lncRNA HOXD-AS1 regulates proliferation and chemo-resistance of castration-resistant prostate cancer via recruiting WDR5. Mol Ther. 2017;25(8):1959–1973. doi:10.1016/j.ymthe.2017.04.016
   PubMed Web of Science ®Google Scholar
• Ding L, Ren J, Zhang D, et al. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33. Carcinogenesis. 2018;39(3):397–406. doi:10.1093/carcin/bgy006
   PubMed Web of Science ®Google Scholar
• Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by suppressing miR-184 expression. Cancer Med. 2017;6(12):2897–2908. doi:10.1002/cam4.1253
   PubMed Web of Science ®Google Scholar
• Yang H, Jiang Z, Wang S, et al. Long non-coding small nucleolar RNA host genes in digestive cancers. Cancer Med. 2019;8(18):7693–7704. doi:10.1002/cam4.2622
   PubMed Web of Science ®Google Scholar
• Huang G, He X, Wei XL. lncRNA NEAT1 promotes cell proliferation and invasion by regulating miR365/RGS20 in oral squamous cell carcinoma. Oncol Rep. 2018;39(4):1948–1956. doi:10.3892/or.2018.6283
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang X, Kai J, et al. HIF-1alpha-upregulated lncRNA-H19 regulates lipid droplet metabolism through the AMPKalpha pathway in hepatic stellate cells. Life Sci. 2020;255:117818. doi:10.1016/j.lfs.2020.117818
   PubMed Web of Science ®Google Scholar
• Ni X, Ding Y, Yuan H, et al. Long non-coding RNA ZEB1-AS1 promotes colon adenocarcinoma malignant progression via miR-455-3p/PAK2 axis. Cell Prolif. 2020;53(1):e12723.
   PubMed Web of Science ®Google Scholar
• Qu R, Chen X, Zhang C. LncRNA ZEB1-AS1/miR-409-3p/ZEB1 feedback loop is involved in the progression of non-small cell lung cancer. Biochem Biophys Res Commun. 2018;507(1–4):450–456. doi:10.1016/j.bbrc.2018.11.059
   PubMed Web of Science ®Google Scholar